Taking your health in hand can sometimes have a very concrete meaning. According to Dr. Daniel Kelly, a specialist in Harvard University and contributor to The Conversation, frequent ejaculation would have a protective effect against prostate cancer, a disease that affects nearly 60,000 men each year in France.
Masturbation, a gesture that protects the prostate?
In his article, Dr. Kelly underlines that regular ejaculation “does not hurt” And “that she must be part of a man’s healthy lifestyle“. An assertion supported by several scientific works, including a vast study by Harvard University published in 2016. This had revealed that”The men who ejaculated 21 times a month were up to a third less likely to be struck by the disease, compared to men who only did it between four and seven times a month“.
What do scientists say about frequent ejaculation?
If the data seem solid, the researchers are still struggling to explain why. As Dr. Kelly explains, “Although the mechanisms are not completely understood, these studies frame with the idea that ejaculation can reduce prostate cancer by reducing the concentration of toxins and crystal structures that can accumulate in prostate and potentially cause tumors“. The expert adds that”Ejaculation can modify the immune response within the prostate, thus reducing inflammation – a risk factor known for the development of cancer – or by increasing immune defenses against tumor cells“.
Beyond the biological aspect, the doctor also notes an effect on stress: “By reducing psychological tension, ejaculation can decrease the activity of the nervous system, which prevents certain prostate cells from dividing too quickly and increases the risk they become cancerous“.
Prostate cancer in figures and risks
Prostate cancer remains the most common cancer in humans in France, with around 60,000 cases diagnosed in 2018. It is rare before 50 years but its incidence then increases rapidly, the average age of detection being 70 years. According to the National Cancer Institute, “Prostate cancer is a disease that develops from initially normal prostate cells which are transformed and multiply anarchically, until forming a mass called malignant tumor“. In 90 % of cases, these are adenocarcinomas, and family history constitute an additional risk factor.